January–March 2021 BUSINESS REVIEW President and CEO Hannu Martola | 27 April 2021
Slide 2: Q1 2021 key figures
Q1 2021 18.3 -8.0 1.4 7.5 net sales, €m net sales change-% EBIT, €m EBIT-% (19.9) (-13.6) (1.2) (5.9) 2 27.4.2021 Detection Technology | Business review January–March 2021
Slide 3: Q1 2021 summary
Q1 2021 Despite the double-digit increase in medical and industrial sales, the beginning of the year was slow as COVID-19 did not loosen its grip on the security market Demand was good for medical CT applications, and continued to be stable in the food, pharmaceutical, and mining industries Stagnati
Q1 SALES SPLIT BY BUSINESS UNIT NET SALES €m YOY CHANGE-% 13% 32% IBU 2.4 11.3 TOTAL NET SALES 18.3 €m MBU 10.1 20.1 55% SBU 5.8 -37.7 6 27.4.2021 Detection Technology | Business review January–March 2021
Slide 7: Q1 sales split by region
Q1 SALES SPLIT BY REGION NET SALES €m YOY CHANGE-% 18% TOTAL NET SALES AMERICAS 1.1 -66.9 6% 18.3 €m APAC 14.0 13.6 77% EMEA 3.2 -24.8 7 27.4.2021 Detection Technology | Business review January–March 2021
Slide 8: Key figures
KEY FIGURES Q1 2021 Q1 2020 FY 2020 Net sales, EUR 1,000 18,323 19,917 81,561 Change in net sales, % -8.0% -13.6% -20.4% Operating profit, EUR 1,000 1,382 1,181 8,714 Operating margin, % 7.5% 5.9% 10.7% R&D costs, EUR 1,000 2,405 2,618 9,827 R&D costs, % of net sales 13.1% 13.1% 12.0% Cash flow from
Slide 9: Strategy
STRATEGY Focused on • Customer acquisition, managing the record number of customers won in 2020, and further improving customer service. • The development of its product portfolio and new product solutions, and acceleration of the product development cycle. • Arranging its organization in compliance
Slide 10: Business outlook
BUSINESS OUTLOOK 5% Anticipates the medical and industrial markets to grow in line with the estimates by the experts given prior COVID-19 outbreak, but the market disturbance caused by the pandemic will continue to affect the security market, which will decrease in H1 of 2021, and take an upward tur
Slide 11: Financial targets
FINANCIAL TARGETS MEDIUM TERM Annual MEDIUM TERM Operating ANNUAL Dividend or sales growth margin returned capital >10% ≥15% 30-60% 11 27.4.2021 Detection Technology | Business review January–March 2021